Efficacy and Safety of the Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and Immediate-release Pregabalin Capsule for Peripheral Neuropathic Pain: A Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Phase III Clinical Trial

Lee Min-Kyung; Jeon Younghoon; Choi Sang Sik; Lee Pyung Bok; Kim Yong-Chul; Suh Jeong Hun; Sim Sung Eun; Song Sun Ok; Ko Youngkwon; Yu Jae Myung; Min Kyungwan; Lee Jae-Hyuk

首页> 外文期刊>Clinical therapeutics >Efficacy and Safety of the Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and Immediate-release Pregabalin Capsule for Peripheral Neuropathic Pain: A Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Phase III Clinical Trial

【24h】

Efficacy and Safety of the Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and Immediate-release Pregabalin Capsule for Peripheral Neuropathic Pain: A Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Phase III Clinical Trial

机译：控释PREGABALIN片剂（GLA5PR GLARS-NF1）和立即释放普雷那巴林胶囊的疗效和安全性，用于外周神经病理疼痛：多中心，随机，双盲，并联，主动控制，期III临床试验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: This study compared the efficacy and safety of controlled-release pregabalin (GLA5PR GLARS-NF1 tablets) with those of an immediate-release pregabalin capsule after 12 weeks' administration to patients with peripheral neuropathic pain.

机译：None

著录项

来源
《Clinical therapeutics》 |2020年第12期|共14页
作者
Lee Min-Kyung; Jeon Younghoon; Choi Sang Sik; Lee Pyung Bok; Kim Yong-Chul; Suh Jeong Hun; Sim Sung Eun; Song Sun Ok; Ko Youngkwon; Yu Jae Myung; Min Kyungwan; Lee Jae-Hyuk;
展开▼
作者单位

Hanyang Univ Myongji Hosp Dept Internal Med Div Endocrinol &

Metab Coll Med 55 Hwasu Ro 14Beon;

Kyungpook Natl Univ Sch Dent Dept Anesthesiol &

Pain Med Daegu South Korea;

Korea Univ Dept Anesthesiol &

Pain Med Guro Hosp Seoul South Korea;

Seoul Natl Univ Bundang Hosp Dept Anesthesiol &

Pain Med Seoul South Korea;

Seoul Natl Univ Hosp Dept Anesthesiol &

Pain Med Seoul South Korea;

Seoul Nanum Pain Clin Seoul South Korea;

Catholic Univ Dept Anesthesiol &

Pain Med Seoul South Korea;

Hyosan Hosp Songhyo Healthcare Fdn Dept Anesthesiol &

Pain Med Daegu South Korea;

Chungnam Natl Univ Dept Anesthesia &

Pain Med Daejeon South Korea;

Hallym Univ Dept Endocrinol &

Internal Med Kangnam Sacred Heart Hosp Seoul South Korea;

Nowon Eulji Med Ctr Dept Endocrinol &

Internal Med Seoul South Korea;

Hanyang Univ Myongji Hosp Dept Internal Med Div Endocrinol &

Metab Coll Med 55 Hwasu Ro 14Beon;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词
controlled-release; efficacy; peripheral neuropathic pain; pregabalin; safety;

机译：控制释放;疗效;外周神经病理疼痛;普瑞巴林;安全;

相似文献

外文文献
中文文献

1. Efficacy and safety of Shexiang Baoxin pill(MUSKARDIA)in patients with stable coronary artery disease:a multicenter,double-blind,placebo-controlled phase Ⅳ randomized clinical trial [J] . Jun-Bo Ge, Ying-Wu Liu, Sheng-Huang Wang, 中华医学杂志（英文版） . 2021,第002期
2. The Efficacy and Safety of Wenxin Keli in Patients with Frequent Premature Ventricular Contractions: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial [J] . Wei Hua, Run-Lin Gao, Bu-Chang Zhao, 中华医学杂志（英文版） . 2015,第019期
3. Evaluation on the efficacy and safety of Chinese herbal medication Xifeng Dingchan Pill in treating Parkinson＇s disease： study protocol of a multicenter, open-label, randomized active-controlled trial [J] . Jie Zhang, Yun-zhi Ma, Xiao-ming Shen 结合医学学报：英文版 . 2013,第004期
4. Comparative Pharmacokinetics of a Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and an Immediate-release Pregabalin Capsule in Healthy Male Volunteers [J] . Kim Tae-Eun, Jeon Ji-Young, Gu Namyi, Clinical therapeutics . 2018,第12期

机译：受控释放的普瑞巴林片剂（GLA5PR Glars-NF1）的比较药代动力学和在健康男性志愿者中立即释放的普瑞巴林胶囊
5. Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial [J] . Khojasteh Joharchi, Moosareza Memari, Eznollah Azargashb, Journal of Diabetes and Metabolic Disorders . 2019,第2期

机译：度洛西汀和普瑞巴林对伊朗糖尿病周围神经性疼痛患者的疗效和安全性：一项双盲，随机临床试验
6. Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trial. [J] . Satoh J, Yagihashi S, Baba M, Diabetic medicine: A journal of the British Diabetic Association . 2011,第1期

机译：普瑞巴林治疗与糖尿病周围神经病变相关的神经性疼痛的功效和安全性：一项为期14周的随机，双盲，安慰剂对照试验。
7. Efficacy and safety of novel collagen conduits filled with collagen filaments to treat patients with peripheral nerve injury: A multicenter, controlled, open-label clinical trial [D] . Saeki Masaomi, 佐伯将臣 2019

机译：充满胶原细丝的新型胶原蛋白导管治疗周围神经损伤患者的疗效和安全性：一项多中心，对照，开放标签的临床试验
8. Correction to: Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind randomized clinical trial [O] . Khojasteh Joharchi, Moosareza Memari, Eznollah Azargashb, 2019

机译：更正：度洛西汀和普瑞巴林在伊朗糖尿病周围神经性疼痛患者中的疗效和安全性：一项双盲随机临床试验
9. Dose-proportional pharmacokinetic properties of GLA5PR GLARS-NF1 controlled-release pregabalin in healthy Korean volunteers: a randomized, open, single-dose, parallel study [O] . Kwang-Hee Shin, Ji-Young Jeon, Kyungho Jang, 2018

机译：剂量 - 比例的Gla5pr Glars-NF1控制释放Prainabalin在健康韩国志愿者中：随机，开放，单剂量，并行研究
10. Randomized Double-Blind Phase III Pivotal Field Trial of the Comparative Immunogenicity Safety and Tolerability of Two Yellow Fever 17D Vaccines (ARILVAX(Trademark) and YF-VAX(Trademark)) in Healthy Infants and Children in Peru [R] . Belmusto-Worn, V. E. , Sanchez, J. L. , McCarthy, K. , 2004

机译：秘鲁健康婴儿和儿童两种黄热病17D疫苗（aRILVaX（商标）和YF-VaX（商标））的比较免疫原性安全性和耐受性的随机双盲III期关键现场试验

Efficacy and Safety of the Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and Immediate-release Pregabalin Capsule for Peripheral Neuropathic Pain: A Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Phase III Clinical Trial

摘要

著录项

相似文献

相关主题

期刊订阅